Plavix, known generically as clopidogrel and sold by Sanofi and Bristol-Myers Squibb, is the world's second biggest selling drug, with worldwide sales of about $9 billion. But it has recently lost patent protection in some European markets.
Wednesday, October 07, 2009
EU antitrust raids - Sanofi and Teva
Sanofi-Aventis, the Paris-based pharmaceutical group, and Israel's Teva, the world's largest generic drugs producer, have been raided by European competition officials in a fresh probe into suspected antitrust breaches believed to have occurred in France.
Coincidentally Sanofi-Aventis is preparing to sell its own generic version of the blockbuster heart medicine Plavix in France, a company spokesman said on Monday.
Plavix, known generically as clopidogrel and sold by Sanofi and Bristol-Myers Squibb, is the world's second biggest selling drug, with worldwide sales of about $9 billion. But it has recently lost patent protection in some European markets.
Plavix, known generically as clopidogrel and sold by Sanofi and Bristol-Myers Squibb, is the world's second biggest selling drug, with worldwide sales of about $9 billion. But it has recently lost patent protection in some European markets.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment